Promoter holding
64.27%
ES
Eagle Seeds & Biotech - Due diligence report
A 360° intelligence report on Eagle Seeds & Biotech: trust score, financial health, credit view, compliance, directors, growth and distress …
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Eagle Seeds & Biotech — 360° Intelligence Report
Generated from MCA filings & public records73/100
Trust Score
Moderate
Eagle Seeds & Biotech is assessed as Moderate with a Trust Score of 73/100. Eagle Seeds & Biotech is an active private limited indian non-government company incorporated in 1997, operating in the Agriculture sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.
Report generated on 26 Sep 2026 from the latest processed filings. Esl Infra Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
73/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
76/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
45/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
45/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
- Negative operating earnings - debt service depends on external support.
- Open charges exceed net worth - secured lenders rank ahead.
- Moderate gearing (D/E 38%).
- Externally credit-rated (MSE).
Charges position: 3 open (160.00 cr) · 5 satisfied (50.74 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 4 | 48.0 cr |
| Others | 2 | 48.0 cr |
| Central Bank Of India | 1 | 48.0 cr |
| Axis Bank Limited | 1 | 48.0 cr |
Compliance Score: 76/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 2 court forum(s).
- 1 auditor resignation(s) filed - latest: J R D & Associates on 2019-01-22.
- 8 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| AJAY ARUN VAIDYA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUMANGALA JAIN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| GULAB SINGHVI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VAIBHAV JAIN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 4 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 5 transfer(s)
Promoters hold a majority stake - exact percentages are part of the full report.
Key managerial personnel: VAIBHAV JAIN (Managing Director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 45 · Distress 65
Growth signals & trust indicators
Asset base grew 1.42 - capacity expansion.
Operating for 29+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Outside liabilities up 2.1x in a year.
3 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence72/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment53/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 3 open charge(s) of 160.00 cr already registered.
- Compliance record supports lending.
Investor view52/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 1 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events24 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
25 Jan 2025
Director appointed
GULAB SINGHVI (Director)
13 Feb 2024
Charge created
Others - 40.00 cr
Charge created
Hdfc Bank Limited - 80.00 cr
21 Sep 2023
Director ceased
GANPATI MAHESHWAR NADKARNI
19 Jun 2023
Charge satisfied
Axis Bank Limited
21 Sep 2022
Director ceased
MOHAN AGRAWAL
Director ceased
AJAY ARUN VAIDYA
Director ceased
SURESH SANJIVA ACHAR
03 Feb 2022
Charge satisfied
Hdfc Bank Limited
07 Dec 2021
Director appointed
AJAY ARUN VAIDYA (Director)
29 Oct 2021
Director ceased
THIRUVANNATHAPURAM SUBRAMANIAN SANKARANARAYANAN
31 Mar 2020
Share transfer (FY 2020)
112250.00000000 shares to Barwale Family Trust
06 Mar 2019
Charge satisfied
Others
10
Key Observations
Auto-generated from the data aboveRevenue declined 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
8 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of MSE from Crisil.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
| Company | CIN | Location |
|---|---|---|
| Hisar Motors Private Limited | U50100HR2010PTC040171 | Hissar, Haryana, India |
| Incom Kits India Private Limited | U36994GJ2019PTC110046 | Daskroi, Gujarat, India |
| Jewel Casa Private Limited | U36996MH2020PTC346998 | Mumbai, Maharashtra, India |
| A.K. Concast Private Limited | U27101PB2010PTC037364 | Ludhiana, Punjab, India |
| Khivraj Vahan Private Limited | U34101TN2007PTC065186 | Chennai, Tamil Nadu, India |
| Taximens Services Limited | U51900MH1973PLC016990 | Mumbai, Maharashtra, India |
| Harish Bakers And Confectioners Private Limited | U15412DL2003PTC119541 | New Delhi, Delhi, India |
| Jayant Dal Mills Private Limited | U15313WB2011PTC161476 | Bally Jagachha, West Bengal, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Eagle Seeds & Biotech before audits and certifications: compliance score 76/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Eagle Seeds & Biotech: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 45/100, margin trends, ownership structure and peer set for Eagle Seeds & Biotech - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 73/100, distress signals and MSME payment-delay disclosures - know whether Eagle Seeds & Biotech pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Eagle Seeds & Biotech - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Eagle Seeds & Biotech an active company?
Eagle Seeds & Biotech has MCA status “Active” with a compliance score of 76/100 (Low Risk).
Is Eagle Seeds & Biotech financially healthy?
Eagle Seeds & Biotech has a Financial Health Score of 45/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Eagle Seeds & Biotech?
Its overall Trust Score is 73/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Eagle Seeds & Biotech?
Promoters hold a majority stake - exact percentages are in the full report. 4 active director(s) are on record.
Does Eagle Seeds & Biotech have loans or charges against its assets?
3 open charge(s) are registered against its assets, and 5 earlier charge(s) stand satisfied.
Is Eagle Seeds & Biotech up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 76/100 (Low Risk).
Is it risky to lend to Eagle Seeds & Biotech?
Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
